HDAC6 and inflammatory breast carcinoma: Future studies should further investigate the mechanistic basis of the sensitivity of IBC cells to HDAC6 inhibition and the predictive potential of the HDAC6 score in order to efficiently apply targeted HDAC6 therapy in IBC.